Knockdown of the PPARγ gene affects the expression of several genes associated with Alzheimer’s disease, suggesting that pioglitazone may regulate the transcription of genes related to Alzheimer’s disease and may potentially affect the risk of dementia [20]. This evidence concerns the gene PPARG and dementia.